| PDB code | Main view | Title | | 1apo |  | Three-dimensional structure of the apo form of the n- terminal egf-like module of blood coagulation factor x as determined by nmr spectroscopy and simulated folding |
| 1apq |  | Structure of the egf-like module of human c1r, nmr, 19 structures |
| 1aut |  | Human activated protein c |
| 1bf9 |  | N-terminal egf-like domain from human factor vii, nmr, 23 structures |
| 1c5m |  | Structural basis for selectivity of a small molecule, s1- binding, sub-micromolar inhibitor of urokinase type plasminogen activator |
| 1ccf |  | How an epidermal growth factor (egf)-like domain binds calcium-high resolution nmr structure of the calcium form of the nh2-terminal egf-like domain in coagulation factor x |
| 1dan |  | Complex of active site inhibited human blood coagulation factor viia with human recombinant soluble tissue factor |
| 1dva |  | Crystal structure of the complex between the peptide exosite inhibitor e-76 and coagulation factor viia |
| 1edm |  | Epidermal growth factor-like domain from human factor ix |
| 1emn |  | Nmr study of a pair of fibrillin ca2+ binding epidermal growth factor-like domains, minimized average structure |
| 1emo |  | Nmr study of a pair of fibrillin ca2+ binding epidermal growth factor-like domains, 22 structures |
| 1ezq |  | Crystal structure of human coagulation factor xa complexed with rpr128515 |
| 1f0r |  | Crystal structure of human coagulation factor xa complexed with rpr208815 |
| 1f0s |  | Crystal structure of human coagulation factor xa complexed with rpr208707 |
| 1f7e |  | The first egf-like domain from human blood coagulation fvii, nmr, 20 structures |
| 1f7m |  | The first egf-like domain from human blood coagulation fvii, nmr, minimized average structure |
| 1fak |  | Human tissue factor complexed with coagulation factor viia inhibited with a bpti-mutant |
| 1fax |  | Coagulation factor xa inhibitor complex |
| 1ff7 |  | The first egf-like domain from human blood coagulation fvii (fucosylated at ser-60), nmr, 20 structures |
| 1ffm |  | The first egf-like domain from human blood coagulation fvii (fucosylated at ser-60), nmr, minimized average structure |
| 1g2l |  | Factor xa inhibitor complex |
| 1g2m |  | Factor xa inhibitor complex |
| 1hj7 |  | Nmr study of a pair of ldl receptor ca2+ binding epidermal growth factor-like domains, 20 structures |
| 1hz8 |  | Solution structure and backbone dynamics of a concatemer of egf-homology modules of the human low density lipoprotein receptor |
| 1i0u |  | Solution structure and backbone dynamics of a concatemer of egf-homology modules of the human low density lipoprotein receptor |
| 1ioe |  | Human coagulation factor xa in complex with m55532 |
| 1iqe |  | Human coagulation factor xa in complex with m55590 |
| 1iqf |  | Human coagulation factor xa in complex with m55165 |
| 1iqg |  | Human coagulation factor xa in complex with m55159 |
| 1iqh |  | Human coagulation factor xa in complex with m55143 |
| 1iqi |  | Human coagulation factor xa in complex with m55125 |
| 1iqj |  | Human coagulation factor xa in complex with m55124 |
| 1iqk |  | Human coagulation factor xa in complex with m55113 |
| 1iql |  | Human coagulation factor xa in complex with m54476 |
| 1iqm |  | Human coagulation factor xa in complex with m54471 |
| 1iqn |  | Human coagulation factor xa in complex with m55192 |
| 1ixa |  | The three-dimensional structure of the first egf-like module of human factor ix: comparison with egf and tgf-a |
| 1ksn |  | Crystal structure of human coagulation factor xa complexed with fxv673 |
| 1lmj |  | Nmr study of the fibrillin-1 cbegf12-13 pair of ca2+ binding epidermal growth factor-like domains |
| 1lpg |  | Crystal structure of fxa in complex with 79. |
| 1lpk |  | Crystal structure of fxa in complex with 125. |
| 1lpz |  | Crystal structure of fxa in complex with 41. |
| 1lqd |  | Crystal structure of fxa in complex with 45. |
| 1n7d |  | Extracellular domain of the ldl receptor |
| 1nfu |  | Crystal structure of human coagulation factor xa complexed with rpr132747 |
| 1nfw |  | Crystal structure of human coagulation factor xa complexed with rpr209685 |
| 1nfx |  | Crystal structure of human coagulation factor xa complexed with rpr208944 |
| 1nfy |  | Crystal structure of human coagulation factor xa complexed with rpr200095 |
| 1nt0 |  | Crystal structure of the cub1-egf-cub2 region of masp2 |
| 1nzi |  | Crystal structure of the cub1-egf interaction domain of complement protease c1s |
| 1o5d |  | Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) |
| 1p0s |  | Crystal structure of blood coagulation factor xa in complex with ecotin m84r |
| 1pfx |  | Porcine factor ixa |
| 1szb |  | Crystal structure of the human mbl-associated protein 19 (map19) |
| 1toz |  | Nmr structure of the human notch-1 ligand binding region |
| 1uzj |  | Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, holo form. |
| 1uzk |  | Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, ca bound to cbegf23 domain only |
| 1uzp |  | Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, sm bound form cbegf23 domain only. |
| 1uzq |  | Integrin binding cbegf22-tb4-cbegf33 fragment of human fibrillin-1, apo form cbegf23 domain only. |
| 1w0y |  | Tf7a_3771 complex |
| 1w2k |  | Tf7a_4380 complex |
| 1whe |  | Coagulation factor, nmr, 20 structures |
| 1whf |  | Coagulation factor, nmr, 15 structures |
| 1wqv |  | Human factor viia-tissue factor complexed with propylsulfonamide-d-thr-met-p-aminobenzamidine |
| 1wss |  | Human factor viia-tissue factor in complex with peprid mimetic inhibitor that has two charge groups in p2 and p4 |
| 1wtg |  | Human factor viia-tissue factor complexed with ethylsulfonamide-d-biphenylalanine-gln-p-aminobenzamidine |
| 1wu1 |  | Factor xa in complex with the inhibitor 4-[(5-chloroindol-2- yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine |
| 1wun |  | Human factor viia-tissue factor complexed with ethylsulfonamide-d-trp-gln-p-aminobenzamidine |
| 1wv7 |  | Human factor viia-tissue factor complexed with ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine |
| 1x7a |  | Porcine factor ixa complexed to 1-{3-[amino(imino) methyl]phenyl}-n-[4-(1h-benzimidazol-1-yl)-2-fluorophenyl]- 3-(trifluoromethyl)-1h-pyrazole-5-carboxamide |
| 1xka |  | Factor xa complexed with a synthetic inhibitor fx-2212a, (2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
| 1xkb |  | Factor xa complexed with a synthetic inhibitor fx-2212a, (2s)-(3'-amidino-3-biphenylyl)-5-(4-pyridylamino)pentanoic acid |
| 1z6c |  | Solution structure of an egf pair (egf34) from vitamin k- dependent protein s |
| 1z6j |  | Crystal structure of a ternary complex of factor viia/tissue factor/pyrazinone inhibitor |
| 2a2q |  | Complex of active-site inhibited human coagulation factor viia with human soluble tissue factor in the presence of ca2+, mg2+, na+, and zn2+ |
| 2aei |  | Crystal structure of a ternary complex of factor viia/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]- 3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2- pyridinyl]oxy]-benzoic acid |
| 2aer |  | Crystal structure of benzamidine-factor viia/soluble tissue factor complex. |
| 2b7d |  | Factor viia inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in a baboon thrombosis model |
| 2b8o |  | Crystal structure of glu-gly-arg-chloromethyl ketone-factor viia/soluble tissue factor complex |
| 2bo2 |  | Egf domains 1,2,5 of human emr2, a 7-tm immune system molecule, in complex with calcium. |
| 2boh |  | Crystal structure of factor xa in complex with compound "1" |
| 2bou |  | Egf domains 1,2,5 of human emr2, a 7-tm immune system molecule, in complex with barium. |
| 2box |  | Egf domains 1,2,5 of human emr2, a 7-tm immune system molecule, in complex with strontium. |
| 2c4f |  | Crystal structure of factor vii.stf complexed with pd0297121 |
| 2cji |  | Crystal structure of a human factor xa inhibitor complex |
| 2ec9 |  | Crystal structure analysis of human factor viia , souluble tissue factor complexed with bcx-3607 |
| 2f9b |  | Discovery of novel heterocyclic factor viia inhibitors |
| 2fir |  | Crystal structure of dfpr-viia/stf |
| 2flb |  | Discovery of a novel hydroxy pyrazole based factor ixa inhibitor |
| 2flr |  | Novel 5-azaindole factor viia inhibitors |
| 2h9e |  | Crystal structure of fxa/selectide/napc2 ternary complex |
| 2j2u |  | Crystal structure of a human factor xa inhibitor complex |
| 2j34 |  | Crystal structure of a human factor xa inhibitor complex |
| 2j38 |  | Crystal structure of a human factor xa inhibitor complex |
| 2j4i |  | Crystal structure of a human factor xa inhibitor complex |
| 2j94 |  | Crystal structure of a human factor xa inhibitor complex |
| 2j95 |  | Crystal structure of a human factor xa inhibitor complex |
| 2uwl |  | Selective and dual action orally active inhibitors of thrombin and factor xa |
| 2uwo |  | Selective and dual action orally active inhibitors of thrombin and factor xa |
| 2uwp |  | Factor xa inhibitor complex |
| 2vh0 |  | Structure and property based design of factor xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs |
| 2vh6 |  | Structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with biaryl p4 motifs |
| 2vj2 |  | Human jagged-1, domains dsl and egfs1-3 |
| 2vj3 |  | Human notch-1 egfs 11-13 |
| 2w2m |  | Wt pcsk9-deltac bound to wt egf-a of ldlr |
| 2w2n |  | Wt pcsk9-deltac bound to egf-a h306y mutant of ldlr |
| 2w2o |  | Pcsk9-deltac d374y mutant bound to wt egf-a of ldlr |
| 2w2p |  | Pcsk9-deltac d374a mutant bound to wt egf-a of ldlr |
| 2w2q |  | Pcsk9-deltac d374h mutant bound to wt egf-a of ldlr |
| 2w86 |  | Crystal structure of fibrillin-1 domains cbegf9hyb2cbegf10, calcium saturated form |
| 2zp0 |  | Human factor viia-tissue factor complexed with benzylsulfonamide-d-ile-gln-p-aminobenzamidine |
| 2zwl |  | Human factor viia-tissue factor complexed with highly selective peptide inhibitor |
| 2zzu |  | Human factor viia-tissue factor complexed with ethylsulfonamide-d-5-(3-carboxybenzyloxy)-trp-gln-p- aminobenzamidine |
| 3bps |  | Pcsk9:egf-a complex |
| 3dem |  | Cub1-egf-cub2 domain of human masp-1/3 |
| 3ela |  | Crystal structure of active site inhibited coagulation factor viia mutant in complex with soluble tissue factor |
| 3ens |  | Crystal structure of human fxa in complex with methyl (2z)- 3-[(3-chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1- (2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate |
| 3gcw |  | Pcsk9:egfa(h306y) |
| 3gcx |  | Pcsk9:egfa (ph 7.4) |
| 3hpt |  | Crystal structure of human fxa in complex with (s)-2-cyano- 1-(2-methylbenzofuran-5-yl)-3-(2-oxo-1-(2-oxo-2- (pyrrolidin-1-yl)ethyl)azepan-3-yl)guanidine |